![Focus research 2022 METAML team](https://www.crct-inserm.fr/wp-content/uploads/2021/10/2017-Farge-et-al-Cover.gif)
![Focus research 2022 METAML team](https://www.crct-inserm.fr/wp-content/uploads/2021/10/2017-Farge-et-al-Cover.gif)
![Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms](https://www.crct-inserm.fr/wp-content/uploads/2023/07/Image-RuxoBaf.jpg)
Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms
Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms Autophagy, Protein Phosphatase 2A, Myeloproliferative neoplasms. Carine Joffre and Véronique De-Mas team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia The...![CD36 drives metastasis and relapse in acute myeloid leukemia](https://www.crct-inserm.fr/wp-content/uploads/2021/11/inserm_54928_-LeucemieAigueMyeloide_IAU-1.png)
CD36 drives metastasis and relapse in acute myeloid leukemia
CD36 drives metastasis and relapse in acute myeloid leukemia Acute myeloid leukemia, metastasis, CD36, relapse. Thomas Farge , Jean Nakhle audrey Carrière-Pazat Team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemiaet METABOLINK of Restore...![A new target to fight certain aggressive leukaemias](https://www.crct-inserm.fr/wp-content/uploads/2023/04/image-sabatier-cancer-discovery.jpg)
A new target to fight certain aggressive leukaemias
A new target to fight certain aggressive leukaemias Acute Myeloid Leukemia, FLT3, C/AAT-enhancer binding protein α, Jean-Emmanuel Sarry Team METAML- Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia . Researchers from the Toulouse Cancer Research...![Jean-Emmanuel Sarry receives the Guy Lazorthes Prize of the Academy of Sciences 2022](https://www.crct-inserm.fr/wp-content/uploads/2022/10/logo.png)
Jean-Emmanuel Sarry receives the Guy Lazorthes Prize of the Academy of Sciences 2022
Talents& Awards AWARD The Guy Lazorthes 2022 prize is awarded to Jean-Emmanuel SARRY. Inserm research director, head of the Metabolism and therapeutic resistance in acute myeloid leukaemia team at the Toulouse Cancer Research Centre (CRCT –...![Laura Poillet-Perez receives the 2021 Olga Sain prize by the Paris committee of the league against cancer](https://www.crct-inserm.fr/wp-content/uploads/2021/08/logo-ligue-contre-le-cancer-1080x675.jpg)